Found: 4
Select item for more details and to access through your institution.
Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study.
- Published in:
- Acta Dermato-Venereologica, 2021, v. 101, n. 10, p. 1, doi. 10.2340/00015555-3816
- By:
- Publication type:
- Article
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study—IL PSO (ITALIAN LANDSCAPE PSORIASIS).
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 2, p. 495, doi. 10.3390/jcm13020495
- By:
- Publication type:
- Article
Real‐life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104‐week multicenter retrospective study – IL PSO (ITALIAN LANDSCAPE PSORIASIS).
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 5, p. 1017, doi. 10.1111/jdv.18913
- By:
- Publication type:
- Article
Palmoplantar pustulosis successfully treated with upadacitinib: Report of three cases.
- Published in:
- Australasian Journal of Dermatology, 2023, v. 64, n. 4, p. 568, doi. 10.1111/ajd.14142
- By:
- Publication type:
- Article